Design, synthesis and evaluation of the Brigatinib analogues as potent inhibitors against tertiary EGFR mutants (EGFRdel19/T790M/C797S and EGFRL858R/T790M/C797S)-Reference-Cited by-同舟云学术

Design, synthesis and evaluation of the Brigatinib analogues as potent inhibitors against tertiary EGFR mutants (EGFRdel19/T790M/C797S and EGFRL858R/T790M/C797S)

Published:2022-09 Issue: Volume:72 Page:128729
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Fang Haotian,Wu Yingming,Xiao Qitao,He Dongbo,Zhou Tongrui,Liu Wenzhong,Yang Chun-Hao,Xie Yuli

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference19 articles.

1. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study;Deng;J Hematol Oncol,2020

2. Combination strategies using EGFR-TKi in NSCLC therapy: learning from the gap between pre-clinical results and clinical outcomes;Yang;Int J Biol Sci,2018

3. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers;Roskoski;Pharmacol Res,2019

4. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008

5. EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients;Planchard;Ann Oncol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, preparation and biological evaluation of new Rociletinib-inspired analogs as irreversible EGFR inhibitors to treat non-small-cell-lung cancer;Bioorganic & Medicinal Chemistry;2024-09

2. Chemical Scaffolds for the Clinical Development of Mutant-Selective and Reversible Fourth-Generation EGFR-TKIs in NSCLC;ACS Chemical Biology;2024-03-29

3. Machine Learning-Based Virtual Screening and Identification of the Fourth-Generation EGFR Inhibitors;ACS Omega;2024-01-02

4. Recent Advances on Pyrazole-Pyrimidine/Fused Pyrimidine Hybrids with Anticancer Potential (A Review);Russian Journal of General Chemistry;2023-08

5. Recent advances of novel fourth generation EGFR inhibitors in overcoming C797S mutation of lung cancer therapy;European Journal of Medicinal Chemistry;2023-01